Theratechnologies Inc. reaffirming earnings guidance for the fiscal year 2024. For the year, the company expects revenue guidance range is confirmed between $87 million and $90 million as compared to the 2023 fiscal year results.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.79 CAD | -0.56% | +4.68% | -16.36% |
May. 09 | Theratechnologies Inc. Announces Frank Holler as Chair of the Board of Directors | CI |
May. 09 | Transcript : Theratechnologies Inc. - Shareholder/Analyst Call |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.36% | 60.45M | |
-2.32% | 92.59B | |
+3.16% | 41.43B | |
-11.10% | 33.49B | |
-20.19% | 14.62B | |
-9.41% | 12.77B | |
-12.25% | 11.58B | |
-44.00% | 11.35B | |
+4.49% | 8.97B | |
-6.32% | 8.3B |
- Stock Market
- Equities
- TH Stock
- News Theratechnologies Inc.
- Theratechnologies Inc. Re-Affirms Earnings Guidance for the Fiscal Year 2024